Free Trial

Grom Social Enterprises (GROM) Competitors

Grom Social Enterprises logo
$0.0004 0.00 (0.00%)
(As of 12/20/2024 03:04 PM ET)

GROM vs. KLDO, KBNT, ALFIW, APCXW, ARBEW, AOGOW, AOGOU, ARRWW, AUROW, and AVPTW

Should you be buying Grom Social Enterprises stock or one of its competitors? The main competitors of Grom Social Enterprises include Kaleido Biosciences (KLDO), Kubient (KBNT), Alfi (ALFIW), AppTech Payments (APCXW), Arbe Robotics (ARBEW), Arogo Capital Acquisition (AOGOW), Arogo Capital Acquisition (AOGOU), Arrowroot Acquisition (ARRWW), Aurora Innovation (AUROW), and AvePoint (AVPTW). These companies are all part of the "computer software" industry.

Grom Social Enterprises vs.

Kaleido Biosciences (NASDAQ:KLDO) and Grom Social Enterprises (NASDAQ:GROM) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their community ranking, profitability, media sentiment, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.

In the previous week, Kaleido Biosciences' average media sentiment score of 0.00 equaled Grom Social Enterprises'average media sentiment score.

Company Overall Sentiment
Kaleido Biosciences Neutral
Grom Social Enterprises Neutral

Kaleido Biosciences has a net margin of 0.00% compared to Grom Social Enterprises' net margin of -386.01%. Kaleido Biosciences' return on equity of 0.00% beat Grom Social Enterprises' return on equity.

Company Net Margins Return on Equity Return on Assets
Kaleido BiosciencesN/A N/A N/A
Grom Social Enterprises -386.01%-89.97%-70.42%

Kaleido Biosciences received 49 more outperform votes than Grom Social Enterprises when rated by MarketBeat users. However, 100.00% of users gave Grom Social Enterprises an outperform vote while only 57.45% of users gave Kaleido Biosciences an outperform vote.

CompanyUnderperformOutperform
Kaleido BiosciencesOutperform Votes
54
57.45%
Underperform Votes
40
42.55%
Grom Social EnterprisesOutperform Votes
5
100.00%
Underperform Votes
No Votes

Grom Social Enterprises has higher revenue and earnings than Kaleido Biosciences. Grom Social Enterprises is trading at a lower price-to-earnings ratio than Kaleido Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kaleido Biosciences$1.10M0.00-$95.48M-$2.24N/A
Grom Social Enterprises$3.72M0.00-$12.53M-$11.670.00

81.6% of Kaleido Biosciences shares are held by institutional investors. Comparatively, 15.9% of Grom Social Enterprises shares are held by institutional investors. 9.0% of Kaleido Biosciences shares are held by company insiders. Comparatively, 0.0% of Grom Social Enterprises shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Kaleido Biosciences has a beta of -0.06, suggesting that its share price is 106% less volatile than the S&P 500. Comparatively, Grom Social Enterprises has a beta of 1.66, suggesting that its share price is 66% more volatile than the S&P 500.

Summary

Kaleido Biosciences beats Grom Social Enterprises on 7 of the 12 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GROM vs. The Competition

MetricGrom Social EnterprisesComputer & Data IndustryComputer SectorNASDAQ Exchange
Market Cap$4,000.00$84.49B$26.06B$9.08B
Dividend YieldN/A0.83%2.79%4.23%
P/E Ratio0.0051.18238.1117.20
Price / Sales0.00467.383,356.81117.04
Price / CashN/A33.9535.8237.85
Price / Book0.005.808.154.78
Net Income-$12.53M$2.40B$685.86M$225.60M
7 Day PerformanceN/A-2.18%0.42%-1.23%
1 Month PerformanceN/A1.63%5.20%0.46%
1 Year PerformanceN/A55.74%22.39%15.24%

Grom Social Enterprises Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GROM
Grom Social Enterprises
N/A$0.00
flat
N/A-100.0%$4,000.00$3.72M0.00450
KLDO
Kaleido Biosciences
N/AN/AN/AN/A$4,000.00$1.10M0.0076Positive News
Gap Up
KBNT
Kubient
N/AN/AN/A-95.0%$4,000.00$1.17M0.0040Gap Up
High Trading Volume
ALFIW
Alfi
N/A$0.00
flat
N/AN/A$0.00$200,684.000.0040Gap Down
APCXW
AppTech Payments
N/A$0.16
flat
N/A-53.6%$0.00$365,000.000.0018News Coverage
Positive News
Gap Down
ARBEW
Arbe Robotics
N/A$0.14
flat
N/A-17.6%$0.00$1.02M0.00120
AOGOW
Arogo Capital Acquisition
N/A$0.01
flat
N/AN/A$0.00N/A0.00N/A
AOGOU
Arogo Capital Acquisition
N/A$8.50
flat
N/AN/A$0.00N/A0.00N/A
ARRWW
Arrowroot Acquisition
N/A$0.07
+16.7%
N/A-14.4%$0.00N/A0.0098Gap Up
AUROW
Aurora Innovation
N/A$1.57
+18.1%
N/A+181.8%$0.00$2M0.001,700News Coverage
High Trading Volume
AVPTW
AvePoint
N/A$7.15
+1.9%
N/A+389.0%$0.00$315.92M0.001,930

Related Companies and Tools


This page (NASDAQ:GROM) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners